Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants
Kui K. Chan, Timothy J.C. Tan, Krishna K. Narayanan, et al.
Science Advances (2021) Vol. 7, Iss. 8
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
Erik Volz, Swapnil Mishra, Meera Chand, et al.
Nature (2021) Vol. 593, Iss. 7858, pp. 266-269
Open Access | Times Cited: 1189
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.
Science (2021) Vol. 372, Iss. 6549, pp. 1413-1418
Open Access | Times Cited: 573
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution
Tyler N. Starr, Allison J. Greaney, William W. Hannon, et al.
Science (2022) Vol. 377, Iss. 6604, pp. 420-424
Open Access | Times Cited: 239
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species
Ruoke Wang, Qi Zhang, Jiwan Ge, et al.
Immunity (2021) Vol. 54, Iss. 7, pp. 1611-1621.e5
Open Access | Times Cited: 227
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 194
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1137-1150.e6
Open Access | Times Cited: 188
Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains
Tyler N. Starr, Allison J. Greaney, Cameron Stewart, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 11, pp. e1010951-e1010951
Open Access | Times Cited: 163
Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
Xuping Xie, Jing Zou, Camila R. Fontes-Garfias, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 155
Nanotechnology-based strategies against SARS-CoV-2 variants
Xiangang Huang, Edo Kon, Xuexiang Han, et al.
Nature Nanotechnology (2022) Vol. 17, Iss. 10, pp. 1027-1037
Open Access | Times Cited: 102
Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants
Lianghui Zhang, Soumajit Dutta, Shiqin Xiong, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 3, pp. 342-351
Open Access | Times Cited: 75
Learning from prepandemic data to forecast viral escape
Nicole N. Thadani, Sarah F. Gurev, Pascal Notin, et al.
Nature (2023) Vol. 622, Iss. 7984, pp. 818-825
Open Access | Times Cited: 66
Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies
Nur Zawanah Zabidi, Hern Liang Liew, Isra Ahmad Farouk, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 944-944
Open Access | Times Cited: 59
Advances in developing ACE2 derivatives against SARS-CoV-2
Haoran Zhang, Panjing Lv, Jingrui Jiang, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 5, pp. e369-e378
Open Access | Times Cited: 38
A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 98
SARS-CoV-2 evolution in animals suggests mechanisms for rapid variant selection
Laura Bashor, Roderick B. Gagne, Angela M. Bosco‐Lauth, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 44
Open Access | Times Cited: 98
Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature
Filippo Migliorini, Ernesto Torsiello, Filippo Spiezia, et al.
European journal of medical research (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 96
Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion
Mohd Zulkifli Salleh, Jeremy P. Derrick, Zakuan Zainy Deris
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7425-7425
Open Access | Times Cited: 78
ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker
Yuning Chen, Yanan Zhang, Renhong Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 63
ACE2 Shedding and the Role in COVID-19
Jieqiong Wang, Huiying Zhao, Youzhong An
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 63
SARS-CoV-2 Antiviral Therapy
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo
Nariko Ikemura, Shunta Taminishi, Tohru Inaba, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 650
Open Access | Times Cited: 49
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV ‐2
Lianghui Zhang, Krishna K. Narayanan, Laura Cooper, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 11
Open Access | Times Cited: 45
Protective neutralizing epitopes in SARS‐CoV‐2
Hejun Liu, Ian A. Wilson
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 76-92
Open Access | Times Cited: 39
Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests
Filipp Frank, Meredith M. Keen, Anuradha Rao, et al.
Cell (2022) Vol. 185, Iss. 19, pp. 3603-3616.e13
Open Access | Times Cited: 39
The past, current and future epidemiological dynamic of SARS-CoV-2
François Balloux, Cedric C.S. Tan, Leo Swadling, et al.
Oxford Open Immunology (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top